Education
About Us
Working with TipRanks
Follow Us
MAIA Biotechnology, Inc. (MAIA)
:MAIA
RESEARCH TOOLSreports
Total Valuation
MAIA Biotechnology, Inc. has a market cap or net worth of $55.33M. The enterprise value is $58.45M.
Market Cap$55.33M
Enterprise Value$58.45M
Share Statistics
MAIA Biotechnology, Inc. has 29,587,315 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,587,315
Owned by Insiders15.22%
Owned by Institutions1.20%
Financial Efficiency
MAIA Biotechnology, Inc.’s return on equity (ROE) is -41.41 and return on invested capital (ROIC) is -767.48%.
Return on Equity (ROE)-41.41
Return on Assets (ROA)-2.61
Return on Invested Capital (ROIC)-767.48%
Return on Capital Employed (ROCE)-7.67
Revenue Per Employee0.00
Profits Per Employee-1.52M
Employee Count13
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MAIA Biotechnology, Inc. is -0.78. MAIA Biotechnology, Inc.’s PEG ratio is 0.06.
PE Ratio-0.78
PS Ratio―
PB Ratio32.49
Price to Fair Value32.49
Price to FCF-1.19
Price to Operating Cash Flow-1.19
PEG Ratio0.06
Income Statement
In the last 12 months, MAIA Biotechnology, Inc. had revenue of 0.00 and earned -19.77M in profits. Earnings per share was -1.49.
Revenue0.00
Gross Profit0.00
Operating Income-20.18M
Pretax Income-19.77M
Net Income-19.77M
EBITDA-20.18M
Earnings Per Share (EPS)-1.49
Cash Flow
In the last 12 months, operating cash flow was -15.79M and capital expenditures 0.00, giving a free cash flow of -15.79M billion.
Operating Cash Flow-15.79M
Free Cash Flow-15.79M
Free Cash Flow per Share-0.53
Dividends & Yields
MAIA Biotechnology, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-23.79%
50-Day Moving Average1.68
200-Day Moving Average2.39
Relative Strength Index (RSI)65.57
Average Volume (3m)101.31K
Important Dates
MAIA Biotechnology, Inc. upcoming earnings date is Nov 6, 2024, TBA Not Confirmed.
Last Earnings DateAug 19, 2024
Next Earnings DateNov 6, 2024
Ex-Dividend Date―
Financial Position
MAIA Biotechnology, Inc. as a current ratio of 1.53, with Debt / Equity ratio of 0.00%
Current Ratio1.53
Quick Ratio1.53
Debt to Market Cap0.00
Net Debt to EBITDA0.35
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MAIA Biotechnology, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MAIA Biotechnology, Inc. EV to EBITDA ratio is -0.41, with an EV/FCF ratio of -0.64.
EV to Sales0.00
EV to EBITDA-0.41
EV to Free Cash Flow-0.64
EV to Operating Cash Flow-0.64
Balance Sheet
MAIA Biotechnology, Inc. has $8.69M in cash and marketable securities with $463.75K in debt, giving a net cash position of -$8.69M billion.
Cash & Marketable Securities$8.69M
Total Debt$463.75K
Net Cash-$8.69M
Net Cash Per Share-$0.29
Tangible Book Value Per Share$0.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for MAIA Biotechnology, Inc. is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.00
Price Target Upside648.66% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast23.55%